BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 27595918)

  • 1. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.
    ; Gregg EW; Jakicic JM; Blackburn G; Bloomquist P; Bray GA; Clark JM; Coday M; Curtis JM; Egan C; Evans M; Foreyt J; Foster G; Hazuda HP; Hill JO; Horton ES; Hubbard VS; Jeffery RW; Johnson KC; Kitabchi AE; Knowler WC; Kriska A; Lang W; Lewis CE; Montez MG; Nathan DM; Neiberg RH; Patricio J; Peters A; Pi-Sunyer X; Pownall H; Redmon B; Regensteiner J; Rejeski J; Ribisl PM; Safford M; Stewart K; Trence D; Wadden TA; Wing RR; Yanovski SZ
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):913-921. PubMed ID: 27595918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial.
    Look AHEAD Research Group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):801-9. PubMed ID: 25127483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
    ; Wing RR
    Arch Intern Med; 2010 Sep; 170(17):1566-75. PubMed ID: 20876408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial.
    Look AHEAD Research Group
    Diabetologia; 2015 Aug; 58(8):1803-13. PubMed ID: 25972230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
    ; Wing RR; Bolin P; Brancati FL; Bray GA; Clark JM; Coday M; Crow RS; Curtis JM; Egan CM; Espeland MA; Evans M; Foreyt JP; Ghazarian S; Gregg EW; Harrison B; Hazuda HP; Hill JO; Horton ES; Hubbard VS; Jakicic JM; Jeffery RW; Johnson KC; Kahn SE; Kitabchi AE; Knowler WC; Lewis CE; Maschak-Carey BJ; Montez MG; Murillo A; Nathan DM; Patricio J; Peters A; Pi-Sunyer X; Pownall H; Reboussin D; Regensteiner JG; Rickman AD; Ryan DH; Safford M; Wadden TA; Wagenknecht LE; West DS; Williamson DF; Yanovski SZ
    N Engl J Med; 2013 Jul; 369(2):145-54. PubMed ID: 23796131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial.
    Baum A; Scarpa J; Bruzelius E; Tamler R; Basu S; Faghmous J
    Lancet Diabetes Endocrinol; 2017 Oct; 5(10):808-815. PubMed ID: 28711469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Intensive Lifestyle Intervention, Fitness, and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial.
    Pandey A; Patel KV; Bahnson JL; Gaussoin SA; Martin CK; Balasubramanyam A; Johnson KC; McGuire DK; Bertoni AG; Kitzman D; Berry JD;
    Circulation; 2020 Apr; 141(16):1295-1306. PubMed ID: 32134326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binge eating and weight loss outcomes in overweight and obese individuals with type 2 diabetes: results from the Look AHEAD trial.
    Gorin AA; Niemeier HM; Hogan P; Coday M; Davis C; DiLillo VG; Gluck ME; Wadden TA; West DS; Williamson D; Yanovski SZ;
    Arch Gen Psychiatry; 2008 Dec; 65(12):1447-55. PubMed ID: 19047532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study.
    Look AHEAD Research Group
    Diabetologia; 2017 Jun; 60(6):980-988. PubMed ID: 28349174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fiber intake and plasminogen activator inhibitor-1 in type 2 diabetes: Look AHEAD (Action for Health in Diabetes) trial findings at baseline and year 1.
    Belalcazar LM; Anderson AM; Lang W; Schwenke DC; Haffner SM; Yatsuya H; Rushing J; Vitolins MZ; Reeves R; Pi-Sunyer FX; Tracy RP; Ballantyne CM;
    J Acad Nutr Diet; 2014 Nov; 114(11):1800-10.e2. PubMed ID: 25131348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical Activity and Weight Loss Among Adults With Type 2 Diabetes and Overweight or Obesity: A Post Hoc Analysis of the Look AHEAD Trial.
    Huang Z; Zhuang X; Huang R; Liu M; Xu X; Fan Z; Dai R; Li H; Xiong Z; Guo Y; Liang Q; Liao X
    JAMA Netw Open; 2024 Feb; 7(2):e240219. PubMed ID: 38386318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study.
    Jakicic JM; Jaramillo SA; Balasubramanyam A; Bancroft B; Curtis JM; Mathews A; Pereira M; Regensteiner JG; Ribisl PM;
    Int J Obes (Lond); 2009 Mar; 33(3):305-16. PubMed ID: 19153582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in Cardiometabolic Risk Factors Associated With Magnitude of Weight Regain 3 Years After a 1-Year Intensive Lifestyle Intervention in Type 2 Diabetes Mellitus: The Look AHEAD Trial.
    Berger SE; Huggins GS; McCaffery JM; Jacques PF; Lichtenstein AH
    J Am Heart Assoc; 2019 Oct; 8(20):e010951. PubMed ID: 31594431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study.
    Gregg EW; Chen H; Bancks MP; Manalac R; Maruthur N; Munshi M; Wing R;
    Diabetologia; 2024 Mar; 67(3):459-469. PubMed ID: 38233592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of Treatment Effects From an Intensive Lifestyle Weight Loss Intervention on Cardiovascular Events in Patients With Type 2 Diabetes: Data From the Look AHEAD Trial.
    de Vries TI; Dorresteijn JAN; van der Graaf Y; Visseren FLJ; Westerink J
    Diabetes Care; 2019 Oct; 42(10):1988-1994. PubMed ID: 31416897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.
    Griffin SJ; Rutten GEHM; Khunti K; Witte DR; Lauritzen T; Sharp SJ; Dalsgaard EM; Davies MJ; Irving GJ; Vos RC; Webb DR; Wareham NJ; Sandbæk A
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):925-937. PubMed ID: 31748169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
    Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
    Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Association of Depression Symptoms and Antidepressant Medication Use With Incident Cardiovascular Events in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Type 2 Diabetes.
    Hazuda HP; Gaussoin SA; Wing RR; Yanovski SZ; Johnson KC; Coday M; Wadden TA; Horton ES; Van Dorsten B; Knowler WC;
    Diabetes Care; 2019 May; 42(5):910-918. PubMed ID: 30833373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study.
    ; Bray G; Gregg E; Haffner S; Pi-Sunyer XF; WagenKnecht LE; Walkup M; Wing R
    Diab Vasc Dis Res; 2006 Dec; 3(3):202-15. PubMed ID: 17160917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
    Ueki K; Sasako T; Okazaki Y; Kato M; Okahata S; Katsuyama H; Haraguchi M; Morita A; Ohashi K; Hara K; Morise A; Izumi K; Ishizuka N; Ohashi Y; Noda M; Kadowaki T;
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):951-964. PubMed ID: 29079252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.